SeraCare Life Sciences Expands Gaithersburg, Maryland, Operations Center
06/22/2015
According to company officials, “with strategic investments to expand laboratory and manufacturing space, this new Molecular Diagnostics Center of Excellence for product development and manufacturing will now also provide digital PCR, Next Generation Sequencing technologies and bioinformatics resources to help accelerate the company's goal of enabling precision medicine."
"SeraCare is fully committed to enabling precision medicine through the development of innovative technologies and tools. These new investments in both infrastructure and top notch talent at our Gaithersburg R&D facility are key in allowing us to develop ground-breaking solutions to support the safe and effective expansion of precision-driven diagnostics," says Charlie Mamrak, CEO, SeraCare Life Sciences.
Most Read
-
-
Why are Foreign Trade Zones Making a Comeback?
Q3 2020
-
The New Normal in the Automotive Supply Chain
2020 Auto/Aero Site Guide
-
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Q1 2020
-
Infrastructure Investment as an Economic Stimulus Tool
Q3 2020
-
Nondisclosure Agreements Best Practices When Negotiating Incentives
Q4 2020
-
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Q3 2019